Inventor · disambiguated record
Tracey L. Mclaughlin
Also filed as: MCLAUGHLIN TRACEY L
10 granted patents·4 pending applications·59 citations·filing 2016–2025
90Inventor score
Files withUNIV LELAND STANFORD JUNIOR7EIGER BIOPHARMACEUTICALS INC3THE BOT OF THE LELAND STANFORD JUNIOR UNIV3THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIO1
Top patents by PatentIndex Score
14 records- 0196US10993991B2Treatment of post-bariatric hypoglycemia with exendin (9-39)THE BOT OF THE LELAND STANFORD JUNIOR UNIV·Filed 2020·Granted May 4, 2021·8 cites·29 claims
- 0296US10993992B2Treatment of post-bariatric hypoglycemia with GLP-1 antagonistsTHE BOT OF THE LELAND STANFORD JUNIOR UNIV·Filed 2020·Granted May 4, 2021·8 cites·32 claims
- 0395US11622995B2Treatment of post-bariatric hypoglycemia with GLP-1 antagonistsUNIV LELAND STANFORD JUNIOR·Filed 2021·Granted Apr 11, 2023·3 cites·25 claims
- 0495US11617782B2Treatment of post-bariatric hypoglycemia with exendin (9-39)UNIV LELAND STANFORD JUNIOR·Filed 2021·Granted Apr 4, 2023·3 cites·25 claims
- 0595US10639354B2Treatment of hyperinsulinemic hypoglycemia with exendin (9-39)THE BOT OF THE LELAND STANFORD JUNIOR UNIV·Filed 2016·Granted May 5, 2020·11 cites·23 claims
- 0694US12220444B2Treatment of hyperinsulinemic hypoglycemia with GLP-1 antagonist exendin(9-39)UNIV LELAND STANFORD JUNIOR·Filed 2023·Granted Feb 11, 2025·1 cites·19 claims
- 0794US12102663B2Treatment of post-bariatric hypoglycemia with exendin (9-39)UNIV LELAND STANFORD JUNIOR·Filed 2023·Granted Oct 1, 2024·1 cites·20 claims
- 0894US11738086B2Methods of using buffered formulations of exendin (9-39)EIGER BIOPHARMACEUTICALS INC·Filed 2021·Granted Aug 29, 2023·5 cites·26 claims
- 0990US10660937B2Treatment of hyperinsulinemic hypoglycemia with GLP-1 antagonist exendin(9-39)THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIO·Filed 2016·Granted May 26, 2020·11 cites·19 claims
- 1089US11020484B2Buffered formulations of exendin (9-39)EIGER BIOPHARMACEUTICALS INC·Filed 2017·Granted Jun 1, 2021·8 cites·30 claims
- 1189US2025082730A1Treatment of post-bariatric hypoglycemia with exendin (9-39)UNIV LELAND STANFORD JUNIOR·Filed 2024·Application pending·0 cites
- 1279US2024042035A1Buffered Formulations Of Exendin (9-39)EIGER BIOPHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1375US2025255935A1Treatment of post-bariatric hypoglycemia with glp-1 antagonist exendin(9-39)UNIV LELAND STANFORD JUNIOR·Filed 2025·Application pending·0 cites
- 1455US2022406400A1Systems and Methods to Identify Metabolic Subphenotypes and Uses ThereofUNIV LELAND STANFORD JUNIOR·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tracey L. Mclaughlin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →